University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Heinemann, L"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 9.

Pandha, S, Heinemann, L, Simpson, GR, Boxall, A, Relph, K and Morgan, R (2011) Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer In: Annual Meeting of the Society-of-Academic-and-Research-Surgery, 2011-01-05 - 2011-01-06, Royal Coll Surgery, Dublin, IRELAND.

Heinemann, L, Simpson, GR, Boxall, A, Kottke, T, Relph, KL, Vile, R, Melcher, A, Prestwich, R, Harrington, KJ, Morgan, R and Pandha, HS (2011) Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer. BMC Cancer, 11.

Heinemann, L, Simpson, GR, Annels, NE, Vile, R, Melcher, A, Prestwich, R, Harrington, KJ and Pandha, HS (2010) The Effect of Cell Cycle Synchronization on Tumor Sensitivity to Reovirus Oncolysis MOLECULAR THERAPY, 18 (12). pp. 2085-2093.

Pandha, Hardev, Heinemann, Lucy, Simpson, Guy, Melcher, A, Prestwich, R, Errington, F, Coffey, M, Harrington, KJ and Morgan, Richard (2009) Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma Clinical Cancer Research, 15 (19). pp. 6158-6166.

Heinemann, L, Kottke, T, Vile, R, Coffey, MC, Harrington, K, Melcher, A and Pandha, HS (2008) Synergistic Anti-Tumor Activity of Oncolytic Reovirus and Docetaxel in a PC-3 Prostate Cancer Mouse Model In: 23rd Annual Scientific Meeting of the International-Society-for-Biological-Therapy-of-Cancer, 2008-10-31 - 2008-11-02, San Diego, CA.

Heinemann, L, Simpson, G, Harrington, K, Melcher, A, Coffey, MC and Pandha, HS (2008) Synergistic anti-tumour activity of oncolytic Reovirus and cisplatin in a B16.F10 mouse melanoma model In: 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, 2008-10-21 - 2008-10-24, Geneva, SWITZERLAND.

Comins, C, Heinemann, L, Harrington, K, Melcher, A, De Bono, J and Pandha, H (2008) Reovirus: Viral therapy for cancer 'as nature intended' CLINICAL ONCOLOGY, 20 (7). pp. 548-554.

White, CL, Twigger, KR, Vidal, L, De Bono, JS, Coffey, M, Heinemann, L, Morgan, R, Merrick, A, Errington, F, Vile, RG, Melcher, AA, Pandha, HS and Harrington, KJ (2008) Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial GENE THERAPY, 15 (12). pp. 911-920.

Twigger, K, Vidal, L, White, CL, De Bono, JS, Bhide, S, Coffey, M, Thompson, B, Vile, RG, Heinemann, L, Pandha, HS, Errington, F, Melcher, AA and Harrington, KJ (2008) Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy CLINICAL CANCER RESEARCH, 14 (3). pp. 912-923.

This list was generated on Sun Mar 29 06:16:47 2020 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800